Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

The Westin Boston Seaport District

Mar 02, 2026 11:00 AM - Mar 04, 2026 12:30 PM

425 Summer Street, Boston, MA 02210, USA

Medical Affairs and Scientific Communications Forum

The longest running neutral forum cultivating interdepartmental relationships in medical affairs.

Session 9 Track 3: Beyond the MSL: Build Compliant and Collaborative Field Medical Support for Market Access

Session Chair(s)

Iris  Tam, PharmD

Iris Tam, PharmD

Senior Vice President and Head, Medical Affairs and HEOR

COEUS, United States

Market Access teams are under pressure to demonstrate value to payers, yet the industry’s reflex remains: “Send in the MSL.” Those who’ve worked in payer engagement know this misses the mark. Payers require scientific dialogue that connects evidence to access, the kind delivered by specialized field medical experts such as Managed Care Liaisons (MCLs) and Health Outcomes Liaisons (HOLs).

For Medical Affairs leaders, this is a pivotal and often underleveraged opportunity. By strategically aligning with Market Access colleagues, Medical Affairs can strengthen credibility, accelerate access, and fill genuine business needs, all while operating compliantly across the “firewall.” This session explores how forward-thinking Medical Affairs organizations are redefining their field strategies to bridge science and access, elevate payer engagement, and become indispensable partners to their Market Access counterparts.

Through case examples, panel dialogue, and decades of field experience, participants will learn how to evolve their Medical Affairs field model to deliver both scientific excellence and tangible access impact.

Learning Objective :
  • Recognize the strategic opportunity for Medical Affairs to partner with Market Access through compliant collaboration that advances payer engagement and evidence translation
  • Differentiate between therapeutic MSL roles and payer-facing Field Medical functions in purpose, execution, and impact
  • Illustrate real-world examples of successful cross-functional partnership between Medical Affairs, HEOR, and Market Access

Speaker(s)

David L. Cram, PharmD

Speaker

David L. Cram, PharmD

Takeda, United States

Director, Regional Account Medical Lead

Stuart  O’Brochta, PharmD

Speaker

Stuart O’Brochta, PharmD

Gilead, United States

Executive Medical Value and Evidence Liasion, US Medical Affairs

Jordana  Wollmann, PharmD

Speaker

Jordana Wollmann, PharmD

AstraZeneca, United States

National Clinical Account Director

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.